|
1
|
Fidelity Investments
Boston,
Massachusetts
|
$1.21B
|
+$237M
|
+4,360,046
|
+26%
|
|
|
2
|
|
$1.04B
|
+$976M
|
+17,965,847
|
New
|
|
|
3
|
T. Rowe Price Investment Management
Baltimore,
Maryland
|
$710M
|
+$4.42M
|
+81,433
|
+0.7%
|
|
|
4
|
|
$702M
|
+$59.5M
|
+1,096,313
|
+10%
|
|
|
5
|
RA Capital Management
Boston,
Massachusetts
|
$667M
|
–
|
–
|
–
|
|
|
6
|
Wellington Management Group
Boston,
Massachusetts
|
$407M
|
+$75.3M
|
+1,386,968
|
+25%
|
|
|
7
|
Vanguard Portfolio Management
Malvern,
Pennsylvania
|
$383M
|
+$17.1M
|
+314,006
|
+5%
|
|
|
8
|
Vanguard Capital Management
Malvern,
Pennsylvania
|
$369M
|
+$4.45M
|
+81,978
|
+1%
|
|
|
9
|
State Street
Boston,
Massachusetts
|
$311M
|
+$49.5M
|
+911,179
|
+21%
|
|
|
10
|
Deep Track Capital
Greenwich,
Connecticut
|
$250M
|
–
|
–
|
–
|
|
|
11
|
Geode Capital Management
Boston,
Massachusetts
|
$201M
|
+$14M
|
+258,080
|
+8%
|
|
|
12
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$174M
|
+$109M
|
+2,012,570
|
+206%
|
|
|
13
|
Kynam Capital Management
Princeton,
New Jersey
|
$170M
|
–
|
–
|
–
|
|
|
14
|
Westfield Capital Management
Boston,
Massachusetts
|
$144M
|
-$63.7M
|
-1,173,710
|
-32%
|
|
|
15
|
Caligan Partners
New York
|
$127M
|
+$6.95M
|
+127,917
|
+6%
|
|
|
16
|
Paradigm Biocapital Advisors
New York
|
$124M
|
-$145M
|
-2,665,168
|
-56%
|
|
|
17
|
Bellevue Group
Kuesnacht,
Switzerland
|
$115M
|
+$42.4M
|
+781,238
|
+66%
|
|
|
18
|
|
$111M
|
-$52.3M
|
-963,446
|
-34%
|
|
|
19
|
Maverick Capital
Dallas,
Texas
|
$93.8M
|
+$12.8M
|
+235,504
|
+17%
|
|
|
20
|
Charles Schwab
San Francisco,
California
|
$85.1M
|
+$3.31M
|
+60,864
|
+4%
|
|
|
21
|
Pivotal bioVenture Partners Investment Advisor
San Francisco,
California
|
$82.9M
|
+$2.88M
|
+53,045
|
+4%
|
|
|
22
|
Eventide Asset Management
Boston,
Massachusetts
|
$80.2M
|
+$322K
|
+5,927
|
+0.4%
|
|
|
23
|
|
$78.5M
|
+$4.11M
|
+75,724
|
+6%
|
|
|
24
|
Northern Trust
Chicago,
Illinois
|
$74.4M
|
+$7.37M
|
+135,703
|
+12%
|
|
|
25
|
|
$72.4M
|
+$67.7M
|
+1,245,805
|
New
|
|
